PWPS
AQST icon

Pinnacle Wealth Planning Services’s Aquestive Therapeutics AQST Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.65K Hold
1,598
– – ﹤0.01% 2216
2026
Q1 		$6.63K Buy
+1,598
New +$6.49K ﹤0.01% 2168

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Pinnacle Wealth Planning Services's AQST Position: Q2 2026 in Review

Pinnacle Wealth Planning Services held its Aquestive Therapeutics (AQST) position steady in Q2 2026 at 1,598 shares worth $6.65K. The position accounts for ﹤0.01% of the portfolio, ranked #2216.

Pinnacle Wealth Planning Services first reported a position in AQST in Q1 2026 and has held it in 2 quarters since. 185 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

  • Pinnacle Wealth Planning Services held 1,598 shares of Aquestive Therapeutics worth $6.65K as of Q2 2026.
  • Pinnacle Wealth Planning Services left its Aquestive Therapeutics share count unchanged in Q2 2026.
  • Aquestive Therapeutics made up ﹤0.01% of Pinnacle Wealth Planning Services's portfolio in Q2 2026, its #2216 holding.
  • Pinnacle Wealth Planning Services first reported a position in Aquestive Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 185 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q2 2026, filed 7 Aug 2026.